Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-19-000063
Filing Date
2019-03-19
Accepted
2019-03-19 11:40:31
Documents
39
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0314form10k.htm 10-K 235248
2 EXHIBIT 31.1 skin0314form10kexh31_1.htm EX-31.1 8299
3 EXHIBIT 31.2 skin0314form10kexh31_2.htm EX-31.2 8312
4 EXHIBIT 32.1 skin0314form10kexh32_1.htm EX-32.1 4504
  Complete submission text file 0001554795-19-000063.txt   980868

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20181231.xml EX-101.INS 79009
6 XBRL SCHEMA FILE skin-20181231.xsd EX-101.SCH 13212
7 XBRL CALCULATION FILE skin-20181231_cal.xml EX-101.CAL 23034
8 XBRL DEFINITION FILE skin-20181231_def.xml EX-101.DEF 14630
9 XBRL LABEL FILE skin-20181231_lab.xml EX-101.LAB 92022
10 XBRL PRESENTATION FILE skin-20181231_pre.xml EX-101.PRE 71360
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 19690676
SIC: 6770 Blank Checks